Nesrin Kiral
Research Subjects
Nesrin Kiral has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Sevda Şener Cömert
Department of Pulmonary Diseases, University of Health Sciences, Kartal Dr. Lütfi Kirdar City Hospital, Istanbul, Turkey
3 shared publications - Ali Fidan
Department of Pulmonary Diseases, University of Health Sciences, Kartal Dr. Lütfi Kirdar City Hospital, Istanbul, Turkey
2 shared publications - Benan Çağlayan
Department of Pulmonary Medicine, Istanbul Oncology Hospital, Istanbul 34846, Türkiye
2 shared publications - Berrin Zinnet Eraslan
Kartal Dr. Lütfi Kırdar City Hospital Clinic of Chest Diseases University of Health Sciences Türkiye İstanbul Türkiye
2 shared publications - Coşkun Doğan
Department of Pulmonology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey
2 shared publications - Banu Salepci
Department of Chest Diseases, Yeditepe University Kozyatagi Hospital, Istanbul, Turkey
1 shared publication
Latest Publications
- 28 March 2025
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 49 (1) , 1-6
The Effect of Plasma Osmolality on Prognosis in Non-Massive Pulmonary Embolism
Objective: Plasma osmolality provides insight into fluid and electrolyte balance and can serve as a prognostic marker in critically ill patients. There is limited research on the relationship between plasma osmolality and mortality in pulmonary embolism (PE). The potential role of plasma osmolality in predicting mortality in PE patients is examined in this study. Methods: A retrospective analysis was conducted on patients admitted to the chest diseases ward with acute PE. Data on demographics, comorbidities, clinical and laboratory results, in-hospital mortality, and 30-day mortality were collected. Plasma osmolality was calculated using sodium, plasma glucose, and blood urea nitrogen (BUN) levels at admission. Patients were categorized into hyposmolality, normosmolality, and hyperosmolality groups. Results: The study included 226 patients (100 males, 44.2%), aged 23-90 years. In-hospital mortality occurred in 13 patients (5.8%). The mortality rate was significantly higher in patients with a simplified Pulmonary Embolism Severity Index score ≥1 (P = .031). In addition, lower albumin levels (P = .008) and higher BUN (P = .007) and urea levels (P = .005) were significantly associated with in-hospital mortality. No significant differences in D-dimer, creatinine, glucose, sodium, and osmolality levels were observed between patients who were discharged and those who experienced in-hospital mortality. Mortality rates within 30 days did not significantly differ across osmolality groups (P > .05). Conclusion: This study did not find a significant correlation between plasma osmolality and short-term mortality in patients with acute PE.Cite this article as: Eraslan BZ, Kodalak-Cengiz S, İçmeli ÖS, Kiral N, Şener-Cömert S. The effect of plasma osmolality on prognosis in non-massive pulmonary embolism. Cerrahpaşa Med J. 2025; 49, 0050, doi: 10.5152/cjm.2025.24050.
- 28 March 2025
- Published by AVES YAYINCILIK A.Ş. in Cerrahpasa Medical Journal
- Vol. 49 (1) , 1-6
The Effect of Plasma Osmolality on Prognosis in Non-Massive Pulmonary Embolism
Objective: Plasma osmolality provides insight into fluid and electrolyte balance and can serve as a prognostic marker in critically ill patients. There is limited research on the relationship between plasma osmolality and mortality in pulmonary embolism (PE). The potential role of plasma osmolality in predicting mortality in PE patients is examined in this study. Methods: A retrospective analysis was conducted on patients admitted to the chest diseases ward with acute PE. Data on demographics, comorbidities, clinical and laboratory results, in-hospital mortality, and 30-day mortality were collected. Plasma osmolality was calculated using sodium, plasma glucose, and blood urea nitrogen (BUN) levels at admission. Patients were categorized into hyposmolality, normosmolality, and hyperosmolality groups. Results: The study included 226 patients (100 males, 44.2%), aged 23-90 years. In-hospital mortality occurred in 13 patients (5.8%). The mortality rate was significantly higher in patients with a simplified Pulmonary Embolism Severity Index score ≥1 (P = .031). In addition, lower albumin levels (P = .008) and higher BUN (P = .007) and urea levels (P = .005) were significantly associated with in-hospital mortality. No significant differences in D-dimer, creatinine, glucose, sodium, and osmolality levels were observed between patients who were discharged and those who experienced in-hospital mortality. Mortality rates within 30 days did not significantly differ across osmolality groups (P > .05). Conclusion: This study did not find a significant correlation between plasma osmolality and short-term mortality in patients with acute PE.Cite this article as: Eraslan BZ, Kodalak-Cengiz S, İçmeli ÖS, Kiral N, Şener-Cömert S. The effect of plasma osmolality on prognosis in non-massive pulmonary embolism. Cerrahpaşa Med J. 2025; 49, 0050, doi: 10.5152/cjm.2025.24050.
- Open Access
- 30 September 2020
- Published by Taylor & Francis in Pulmonology
- Vol. 26 (5) , 275-282
Can PET-CT predict diagnostic success in ultrasonography-guided transthoracic fine needle aspiration biopsies in lung cancers?
To examine any correlations between tumor maximum standard uptake values (SUVmax) in positron emission tomography-computed tomography (PET-CT) and homogeneous/heterogeneous tumor FDG uptake in PET-CT, and the diagnostic success of the procedure in thoracic ultrasonography (US)-guided transthoracic fine needle aspiration biopsy (TFNAB). The files of patients who underwent thoracic US-guided TFNAB between 2013 and 2018 were examined. Patients who underwent thoracic US-guided TFNAB and were diagnosed as having primary lung cancer were considered as the US-TFNAB diagnostic group. Patients whose disease was diagnosed as primary lung cancer using a different diagnostic method (e.g. CT-guided biopsies, fiberoptic bronchoscopy) due to a lack of diagnosis despite undergoing thoracic US-guided TFNAB were allocated to the US-TFNAB non-diagnostic group. The clinical and radiologic characteristics and PET-CT parameters of the two groups were compared. A total of 104 patients were included in the study; 79 (76%) patients whose disease was diagnosed using US-guided TFNAB, and 25 (24%) patients whose primary lung cancer could not be diagnosed with US-guided TFNAB. The mean SUVmax value of the US-TFNAB diagnostic group was 19.5 ± 10.1, whereas it was 15.1 ± 8.9 in the US-TFNAB non-diagnostic group (p = 0.016). Whether a lesion showed homogeneous or heterogeneous FDG uptake did not effect diagnostic success (p = 0.289). SUVmax value was the only effective independent factor in the diagnostic success of the procedure (p = 0.035). High SUVmax values in PET-CT in lung cancers may increase the diagnostic success of US guided-TFNAB procedures.
- 30 September 2020
- Published by Taylor & Francis in Pulmonology
- Vol. 26 (5) , 275-282
Open AccessCan PET-CT predict diagnostic success in ultrasonography-guided transthoracic fine needle aspiration biopsies in lung cancers?
To examine any correlations between tumor maximum standard uptake values (SUVmax) in positron emission tomography-computed tomography (PET-CT) and homogeneous/heterogeneous tumor FDG uptake in PET-CT, and the diagnostic success of the procedure in thoracic ultrasonography (US)-guided transthoracic fine needle aspiration biopsy (TFNAB). The files of patients who underwent thoracic US-guided TFNAB between 2013 and 2018 were examined. Patients who underwent thoracic US-guided TFNAB and were diagnosed as having primary lung cancer were considered as the US-TFNAB diagnostic group. Patients whose disease was diagnosed as primary lung cancer using a different diagnostic method (e.g. CT-guided biopsies, fiberoptic bronchoscopy) due to a lack of diagnosis despite undergoing thoracic US-guided TFNAB were allocated to the US-TFNAB non-diagnostic group. The clinical and radiologic characteristics and PET-CT parameters of the two groups were compared. A total of 104 patients were included in the study; 79 (76%) patients whose disease was diagnosed using US-guided TFNAB, and 25 (24%) patients whose primary lung cancer could not be diagnosed with US-guided TFNAB. The mean SUVmax value of the US-TFNAB diagnostic group was 19.5 ± 10.1, whereas it was 15.1 ± 8.9 in the US-TFNAB non-diagnostic group (p = 0.016). Whether a lesion showed homogeneous or heterogeneous FDG uptake did not effect diagnostic success (p = 0.289). SUVmax value was the only effective independent factor in the diagnostic success of the procedure (p = 0.035). High SUVmax values in PET-CT in lung cancers may increase the diagnostic success of US guided-TFNAB procedures.
- 1 January 2020
- Published by Kare Publishing in Journal of İzmir Chest Hospital
- Vol. 34 (1) , 35-42
The Association of the SUVMax Value Measured on PET-CT with the Stage and Survival in Nonsmall Cell Lung Cancers
- 1 January 2020
- Published by Kare Publishing in Journal of İzmir Chest Hospital
- Vol. 34 (1) , 35-42
The Association of the SUVMax Value Measured on PET-CT with the Stage and Survival in Nonsmall Cell Lung Cancers